Supreme Court Will Judge Biosimilar Patent Dance
By EsqSocial Corporation 19/01/17
The U.S. Supreme Court has agreed to review some of the patent dispute resolution provisions of the Biologics Price Competition and Innovation Act (BPCIA). The Court granted certiorari in the dispute between Amgen and Sandoz, where the Federal...
By: Foley & Lardner LLP